Clinical Trial

Virtual hIStology of Crohn's Disease Ex-vivo Resected Anatomical Lesions

Study acronym: VISCERAL
Not Yet Recruiting
View on ClinicalTrials.gov →
Summary
Crohn's disease is a chronic, incurable inflammatory bowel disease with an unpredictable course, characterized by alternating remission and inflammatory flares. Current follow-up strategies are poorly suited to early flare detection, leading to uncontrolled disease progression and complications. A major clinical challenge is distinguishing reversible inflammatory activity from irreversible intestinal fibrosis, as existing imaging techniques lack specificity. This study aims to perform comprehensive ex vivo multiparametric MRI, combined with biophysical measurements and histopathology, on resected intestinal specimens to precisely map inflammation and fibrosis and to validate in vivo MRI-derived biomarkers for personalized therapeutic decision-making.
Protocol Amendment History 1 amendment
This ClinicalTrials.gov record has been amended once since 2026-02-09.
Trial Details
NCT Number NCT07413653
Lead Sponsor Central Hospital, Nancy, France
Conditions Crohn Disease (CD)
Enrollment 60 participants
Start Date 2026-04-01
Primary Completion 2027-04-01 (estimated)
Study Completion 2028-04-01 (estimated)
Updated on ClinicalTrials.gov 2026-02-25